UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,375,515 | -35.3% | 354,026 | +10.4% | 0.00% | – |
| Q2 2023 | $3,674,031 | -26.4% | 320,596 | +29.4% | 0.00% | -100.0% |
| Q1 2023 | $4,991,639 | +13.0% | 247,847 | +27.1% | 0.00% | 0.0% |
| Q4 2022 | $4,419,312 | +17.0% | 194,941 | -3.2% | 0.00% | – |
| Q3 2022 | $3,778,000 | +490.3% | 201,355 | +487.2% | 0.00% | – |
| Q2 2022 | $640,000 | -75.3% | 34,293 | -76.1% | 0.00% | – |
| Q1 2022 | $2,596,000 | -22.0% | 143,667 | -10.5% | 0.00% | – |
| Q4 2021 | $3,328,000 | +247.4% | 160,468 | +436.4% | 0.00% | – |
| Q3 2021 | $958,000 | +137.1% | 29,915 | +127.9% | 0.00% | – |
| Q2 2021 | $404,000 | -86.2% | 13,125 | -84.9% | 0.00% | – |
| Q1 2021 | $2,933,000 | +57.4% | 87,054 | +68.9% | 0.00% | – |
| Q4 2020 | $1,863,000 | -18.2% | 51,555 | -16.6% | 0.00% | – |
| Q3 2020 | $2,278,000 | -16.3% | 61,828 | +2.3% | 0.00% | – |
| Q2 2020 | $2,723,000 | -33.5% | 60,442 | -30.0% | 0.00% | -100.0% |
| Q1 2020 | $4,095,000 | -39.2% | 86,305 | -8.1% | 0.00% | 0.0% |
| Q4 2019 | $6,733,000 | +130.3% | 93,957 | +26.5% | 0.00% | – |
| Q3 2019 | $2,923,000 | -34.0% | 74,284 | +31.0% | 0.00% | – |
| Q2 2019 | $4,429,000 | +415.0% | 56,687 | +293.0% | 0.00% | – |
| Q1 2019 | $860,000 | +144.3% | 14,423 | +18.1% | 0.00% | – |
| Q4 2018 | $352,000 | +8700.0% | 12,211 | +10900.9% | 0.00% | – |
| Q3 2018 | $4,000 | -96.4% | 111 | -96.2% | 0.00% | – |
| Q2 2018 | $112,000 | -36.7% | 2,950 | -60.8% | 0.00% | – |
| Q1 2018 | $177,000 | +84.4% | 7,519 | +54.0% | 0.00% | – |
| Q4 2017 | $96,000 | -89.8% | 4,884 | -95.0% | 0.00% | – |
| Q3 2017 | $942,000 | -7.6% | 98,176 | -40.3% | 0.00% | – |
| Q2 2017 | $1,019,000 | +7.2% | 164,576 | 0.0% | 0.00% | – |
| Q1 2017 | $951,000 | -36.6% | 164,576 | -38.6% | 0.00% | – |
| Q4 2016 | $1,501,000 | +37.6% | 267,990 | +88.0% | 0.00% | – |
| Q3 2016 | $1,091,000 | +2.1% | 142,560 | -1.7% | 0.00% | – |
| Q2 2016 | $1,069,000 | -62.1% | 145,061 | -38.9% | 0.00% | -100.0% |
| Q1 2016 | $2,821,000 | +2156.8% | 237,407 | +3048.6% | 0.00% | – |
| Q4 2015 | $125,000 | – | 7,540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |